Evidence map›Paper›PMID 23249154›Full record

ReviewExpert review of medical devices2012

Polymeric trileaflet prosthetic heart valves: evolution and path to clinical reality.

Thomas E Claiborne, Marvin J Slepian, Syed Hossainy, Danny Bluestein

Abstract readReview
In one paragraph

Review in Expert review of medical devices, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. In Vitro Durability and Stability Testing of a Novel Polymeric Transcatheter Aortic Valve.ASAIO journal (American Society for Artificial Internal Organs : 1992) · 2020
    Article
  11. Article
  12. Article
  13. An in vitro evaluation of turbulence after transcatheter aortic valve implantation.The Journal of thoracic and cardiovascular surgery · 2018
    Article
  14. Article
  15. Prosthetic Aortic Valves: Challenges and Solutions.Frontiers in cardiovascular medicine · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thomas E ClaiborneDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, NY, USA.
Marvin J Slepian
Syed Hossainy
Danny Bluestein

Funding

Optimizing Cardiovascular Device Thromboresistance for Eliminating AnticoagulantsU01EB012487 · NIBIB · STATE UNIVERSITY NEW YORK STONY BROOK · PI BLUESTEIN, DANNY · 2010 to 2014
$6.9M
Optimizing Cardiovascular Devices Thrombogenicity for Eliminating AnticoagulationR01EB008004 · NIBIB · STATE UNIVERSITY NEW YORK STONY BROOK · PI BLUESTEIN, DANNY · 2007 to 2009
$1.7M
NIBIB NIH HHS 1U01EB012487-0NIBIB NIH HHS R01 EB008004NIBIB NIH HHS U01 EB012487
6 · The paper itself

Abstract

Present prosthetic heart valves, while hemodynamically effective, remain limited by progressive structural deterioration of tissue valves or the burden of chronic anticoagulation for mechanical valves. An idealized valve prosthesis would eliminate these limitations. Polymeric heart valves (PHVs), fabricated from advanced polymeric materials, offer the potential of durability and hemocompatibility. Unfortunately, the clinical realization of PHVs to date has been hampered by findings of in vivo calcification, degradation and thrombosis. Here, the authors review the evolution of PHVs, evaluate the state of the art of this technology and propose a pathway towards clinical reality. In particular, the authors discuss the development of a novel aortic PHV that may be deployed via transcatheter implantation, as well as its optimization via device thrombogenicity emulation.

Indexed as

Heart Valve ProsthesisAortic ValveCardiac CatheterizationHeart Valve Prosthesis ImplantationHumansPolymersProsthesis DesignPolymers

Identifiers

PMID23249154
PMCPMC3570260

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.